Cue Biopharma to Present at the 16th Annual PEGS Boston Essential Protein Engineering & Cell Therapy Summit

    NEXT STORY
    Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test
    PREV STORY
    electroCore, Inc. Announces Publication of a Voluntary ex-ante Transparency Tender Notice Award by NHS England to Fund Continued Use of gammaCore™ in England
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Peregrine Pharmaceuticals Reports Financial Results for Third Quarter of Fiscal Year 2016 and Recent Developments

    --Company Focused on Advancing Its Bavituximab Immuno-Oncology Program Through Its Pharmaceutical, Academic and Clinical ...

    author_avatar
    NASDAQ Market News

    Translate Bio Appoints Robert Meyer, MD, to its Board of Directors

    Appointment adds regulatory expertise as Translate Bio advances early and mid-stage pipeline programsLEXINGTON, Mass., ...

    author_avatar
    NASDAQ Market News

    French regulatory agency agrees lacutamab TELLOMAK trial can resume recruitment in Sézary syndrome and mycosis fungoides

    author_avatar
    NASDAQ Market News